Daiichi Sankyo Company, Limited

4568.T
Drug Manufacturers - General
2026/08/21 Updated
Market Cap: $32.8B (¥5.2T)
Stock Price: $18.04 (¥2,868)
Exchange Rate: 1 USD = ¥158.98

【Daiichi Sankyo】Signing of a JPY 200 billion Loan Agreement for Long-term Fundraising | June 17, 2026

Daiichi Sankyo has entered into a JPY 200 billion loan agreement with urban and regional banks on June 17, 2026, to secure long-term working capital. Financial covenants include maintaining a certain level of total capital and net assets; the impact on performance for the March 2027 fiscal year is expected to be minimal.

Importance:
Page Updated: June 17, 2026
IR Disclosure Date: June 17, 2026

Key Figures

  • Principal of Debt: JPY 200 billion
  • Repayment Due Date: June 19, 2029 and June 19, 2031
  • Total Capital Maintenance Ratio: 75% or higher

AI要約

Fundraising and Financial Covenants

Daiichi Sankyo signed a JPY 200 billion loan agreement with urban and regional banks on June 17, 2026, to secure long-term working capital. The agreement includes financial covenants requiring the maintenance of total capital and net assets above certain levels, and stipulating that the consolidated and individual profits and losses do not consecutively incur losses. These conditions ensure financial health while raising funds. The impact on future performance is expected to be minimal.

Future Outlook and Impact

The agreement is expected to have minimal impact on the performance for the fiscal year ending March 2027. By mandating the maintenance of certain ratios of capital and net assets, the company aims to ensure financial stability and pursue long-term financial management. The company plans to continue operations while maintaining financial health.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Daiichi Sankyo Company Limited

Company overview · Stock price · Financial data · All IR

View company page →